Neuraxis, Inc. (NRXS)
AMEX · Common · CUSIP 64134X201
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NRXS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
64134X201
Business: Neuraxis, Inc. is a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children. NeurAxis is dedicated to advancing the science with its’ proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology.

Company Contact

CEO
Brian Carrico
CFO
Timothy Henrichs
Headquarters
11611 N. Meridian Street, Suite 330, Carmel, IN 46032
Phone
812-689-0791
Email Form
Contact Form »
SEC EDGAR Filings
View filings »